School of Medicine
Showing 11-14 of 14 Results
-
Mahesh Pandit
Postdoctoral Scholar, Immunology and Rheumatology
BioI have completed my PhD in Immunology from Yeungnam University, South Korea. I studied adaptive immune cells especially focusing T cells and its relation to autoimmunity and tumor. I worked on different conditional knockout mice to investigate the cellular mechanisms. Similarly, I worked on disease induced mice to study its preventive and therapeutic approaches. Currently, I am working on Translational immunology as a Postdoctoral Researcher at Stanford University department of Immunology and Rheumatology. I focus on Epstein-Barr Virus, B cells and its relation with various autoimmune diseases.
-
Moritz Schaefer
Postdoctoral Scholar, Immunology and Rheumatology
Current Research and Scholarly InterestsI build AI systems that can be asked a question about biomedical data in plain language and show their work well enough to be checked. CellWhisperer (Nature Biotechnology, 2025) links a million RNA-sequencing profiles to the text describing them, so single-cell data can be explored by asking rather than coding. SpatialWhisperer (ICML 2026) carries this into histopathology. I pair these models with AI agents reasoning across imaging, genomics and the clinic to explain why CAR T therapy fails.
-
Laura van Dam
Postdoctoral Scholar, Immunology and Rheumatology
BioI am both trained as a biomedical researcher and medical doctor in internal medicine and strive to close the gap between the clinic and fundamental sciences with translational research. My focus is to study the mechanisms of autoimmune diseases and to translate research insights into therapeutics targeting autoimmunity. I have received my PhD in 2022 in Leiden for studying neutrophil extracellular traps and autoreactive B cells in renal autoimmune diseases. My postdoctoral research project in the Robinson lab focuses on investigating the underlying molecular mechanisms of the pathogenesis of ANCA-associated vasculitis. I particularly aim to identify potential microbial triggers and molecular mimicry in ANCA-associated vasculitis, by characterizing the nasal microbiome and sequencing T cells and B cells of ANCA-associated vasculitis patients.
